Identification of published data on prevalent/incidence of atrial fibrillation/flutter (AF) often relies on inpatient/outpatient claims, without consideration to other types of healthcare services and pharmacy claims. Accurate, population‐level data that… Click to show full abstract
Identification of published data on prevalent/incidence of atrial fibrillation/flutter (AF) often relies on inpatient/outpatient claims, without consideration to other types of healthcare services and pharmacy claims. Accurate, population‐level data that can enable the ongoing monitoring of AF epidemiology, quality of care at affordable cost, and complications are needed. We hypothesised that prevalent/incidence data would vary via the use of integrated medical/pharmacy claims, and associated comorbidities would vary accordingly.
               
Click one of the above tabs to view related content.